Seroprevalence of antibody to HDV in Nigerians with hepatitis B virus-related liver diseases

Nigerian Journal of Clinical Practice

Volumn 12, Issue 4, 2009, Pages 439-442

  Nwokediuko, S C ^a   Ijeoma, U ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Hepatitis B virus; Hepatitis D virus; Sero prevalence

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS DELTA ANTIGEN;

ADULT; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; DELTA AGENT HEPATITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER DISEASE; MALE; MIDDLE AGED; NEGRO; NIGERIA; PROSPECTIVE STUDY; SEX RATIO; TEACHING HOSPITAL; VIROLOGY;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS D; HEPATITIS DELTA ANTIGENS; HEPATITIS DELTA VIRUS; HOSPITALS, TEACHING; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; NIGERIA; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION;

EID: 72849138238     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rizzetto M, Hoyer B, Canese MG, Shih JW, Purcell RH, Gerin JL. Delta agent: Association of delta antigen with hepatitis B surface antigen and RNA in serum of delta infected chimpanzees. Proc. Natl. Acad. Sci USA 1980; 77:6124-6128
2. Ponzetto A, Negro F, Popper H, Bonino F, Eagle R, Rizzetto M, et al. Serial passage of hepatitis delta virus in chronic hepatitis B. virus carrier Chimpanzees. Hepatology 1988; 8:1655-1661 (Pubitemid 19021904)
3. Charkraborty P, Kailash U, Jain A, Goyal R, Gupta RK, Das BC, et al. Seroprevalence of hepatitis D virus in patients with hepatitis B-virus related liver diseases. Indian J Med Res 2005; 122:254-257 (Pubitemid 41645196)
4. Toukan AU al-Kandari S. The role of hepatitis D virus in liver disease in the Middle East. Prog Clin Biol Res 1991; 364:63-68
5. th ed. Churchill Livingstone; 1999; 1287-1828
6. Ponzetto A, Forzani B, Paravicini PP, Hele C, Zanetti A, Rizzetto M. Epidemiology of hepatitis delta virus infection Eur. J. Epidemiol 1985; 1:257 263. (Pubitemid 16127487)
7. Smedile A, Lavarini C, Farci P, Arico S, Marinucci G, Dentico P et al. Epidemiologic patterns of infection with the hepatitis B virus associated delta agent in Italy. Am J Epidemiol 1983; 117:223-229 (Pubitemid 13194926)
8. Tapalaga D, Forzani B, Hele C, Paravacini O, Ponzetto A, Theilmann L. Prevalence of the hepatitis delta virus in Rumania. Hepatogastroenterology 1986; 33:238-239 (Pubitemid 17212765)
9. Olubuyide IO. Natural history of primary liver cell carcinoma: a study of 89 untreated adult Nigerians. Centr. Afr. J. Med 1992; 38:25-30
10. Fakunle YM, Adkokiewez AB, Greenwood MB, Edington GMl. Primary Liver cell carcinoma in Northern Guinea Savannah of Nigeria. Trans R. Soc Trop Med Hyg 1977; 71: 335-337
11. Otu AA. Hepatocellular Carcinoma, Cirrhosis and Hepatitis B infection in Nigeria. Cancer 1987;60:2581-2585.
12. OH JM, Okafor GO. The prevalence of hepatitis B surface antigen in Nigerian diabetics. Tropical Geographical Medicine 1980; 32:40-44.
13. Olubuyide IO, Aliyu B, Olaleye OA, Ola SO, Olawuyi FM, Malabu UH, et al. Hepatitis B and C virus and hepatocellular carcinoma. Trans R Soc Trop Med Hyg 1997; 91:491-492
14. Amazigbo UO, Chime AB. Hepatitis B virus infection in rural and urban populations of eastern Nigeria: Prevalence of serological markers. East African Medical Journal 1990; 67:539-544
15. Belo AC. Prevalence of hepatitis B virus markers in surgeons in Lagos, Nigeria. East African Medical Journal 2000; 77:283-285. (Pubitemid 33209343)
16. Mustapha SK, Pindiga UH. The Prevalence of hepatitis B virus in patients with hepatocellular carcinoma in Gombe, North Eastern Nigeria. Sahel Medical Journal 2003; 6:104-106.
17. Ojo OS, Thursz M, Thomas HC, Ndububa DA, Adeodu OO, Rotimi O et al. Hepatitis B virus markers, hepatitis D virus antigen and hepatitis C virus antibodies in Nigerian patients with chronic liver disease. East Afr. Med. J. 1995; 72(11):719-721.
18. Ojo OS, Akonai, Thursz M, Ndububa DA, Durosimi MA, Adeodu OO et al. Hepatitis D virus antigen in HBsAg positive chronic liver disease in Nigeria. East Afr. Med. J. 1998; 75(6): 329-331.
19. Balik M, Onul E, Tekeli E, Caredda F. Epidemiology and clinical outcome of hepatitis D virus infection in Turkey. European Journal of Epidemio0logy 1991; 7: 48-54.
20. Navascues CA, Rodiguez M, Sotorrio NG, Sala P, Linares A, Suarez A, et al. Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J. Gastroenterol 1995; 90:1981-1984.
21. Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, et al. Chronic hepatitis D: a vanishing disease? An Italian multicentre study.
22. Roingeard P, Sankale JL, Dubois F, Diouf A, Bacha A, Mboup S, et al. Infection due to hepatitis delta virus in Africa: Report from Senegal and review. Clin Infect Dis 1992; 14: 510-514
23. Sebastiao V, Raymund P, Regina C, Adriana P, Vanise M. High Prevalence of Hepatitis B virus and Hepatitis D virus in the Western Brazilian Amazon. Am J Trop Med Hyg 2005; 73(4): 805-814.
24. Kane MA. Global Status of hepatitis B immunization. Lancet 1996; 348:696.
25. Kane MA. Status of hepatitis B immunization programs in 1998. Vaccine 1999; 16: S104 -S108.
26. WHO Vaccines and Biologicals Annual Report 2000. WHO/V & B/01.01; 28-31.